Potential non-invasive biomarkers in tumor immune checkpoint inhibitor therapy: response and prognosis prediction.

Song, Ruixia; Liu, Fengsen; Ping, Yu; Zhang, Yi; Wang, Liping

Song, Ruixia; Liu, Fengsen; Ping, Yu; Zhang, Yi; Wang, Liping.

Afiliación

Song R; Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Liu F; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Ping Y; Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou University, Zhengzhou, Henan, China.
Zhang Y; Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Wang L; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Biomark Res ; 11(1): 57, 2023 Jun 02.

Article en En | MEDLINE | ID: mdl-37268978

Palabras clave

Biomarkers; Cancer; Immune checkpoint inhibitors; Prognosis; Treatment outcome

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Biomark Res Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google